Logo image of ALQGC.PA

QUANTUM GENOMICS SAS-REGR (ALQGC.PA) Stock Fundamental Analysis

Europe - EPA:ALQGC - FR0011648971 - Common Stock

0.0721 EUR
0 (-1.77%)
Last: 10/24/2024, 7:00:00 PM
Fundamental Rating

1

Overall ALQGC gets a fundamental rating of 1 out of 10. We evaluated ALQGC against 77 industry peers in the Biotechnology industry. ALQGC has a bad profitability rating. Also its financial health evaluation is rather negative. ALQGC has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ALQGC has reported negative net income.
ALQGC had negative earnings in each of the past 5 years.
ALQGC had a negative operating cash flow in each of the past 5 years.
ALQGC.PA Yearly Net Income VS EBIT VS OCF VS FCFALQGC.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -10M -20M -30M

1.2 Ratios

With a Return On Assets value of -84.63%, ALQGC is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
ALQGC's Return On Equity of -726.18% is on the low side compared to the rest of the industry. ALQGC is outperformed by 75.71% of its industry peers.
Industry RankSector Rank
ROA -84.63%
ROE -726.18%
ROIC N/A
ROA(3y)-87.78%
ROA(5y)-71.29%
ROE(3y)-517.57%
ROE(5y)-335.54%
ROIC(3y)N/A
ROIC(5y)N/A
ALQGC.PA Yearly ROA, ROE, ROICALQGC.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 -200 -400 -600

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ALQGC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALQGC.PA Yearly Profit, Operating, Gross MarginsALQGC.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 -20K -40K -60K

More info and screens

3

2. Health

2.1 Basic Checks

ALQGC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALQGC has about the same amount of shares outstanding.
The number of shares outstanding for ALQGC has been increased compared to 5 years ago.
Compared to 1 year ago, ALQGC has a worse debt to assets ratio.
ALQGC.PA Yearly Shares OutstandingALQGC.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
ALQGC.PA Yearly Total Debt VS Total AssetsALQGC.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

2.2 Solvency

ALQGC has an Altman-Z score of -11.61. This is a bad value and indicates that ALQGC is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -11.61, ALQGC is not doing good in the industry: 84.29% of the companies in the same industry are doing better.
A Debt/Equity ratio of 4.49 is on the high side and indicates that ALQGC has dependencies on debt financing.
ALQGC's Debt to Equity ratio of 4.49 is on the low side compared to the rest of the industry. ALQGC is outperformed by 72.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.49
Debt/FCF N/A
Altman-Z -11.61
ROIC/WACCN/A
WACC7.48%
ALQGC.PA Yearly LT Debt VS Equity VS FCFALQGC.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M

2.3 Liquidity

ALQGC has a Current Ratio of 2.73. This indicates that ALQGC is financially healthy and has no problem in meeting its short term obligations.
ALQGC has a Current ratio (2.73) which is in line with its industry peers.
A Quick Ratio of 2.73 indicates that ALQGC has no problem at all paying its short term obligations.
With a Quick ratio value of 2.73, ALQGC perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.73
Quick Ratio 2.73
ALQGC.PA Yearly Current Assets VS Current LiabilitesALQGC.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 87.28% over the past year.
The Revenue for ALQGC has decreased by -98.34% in the past year. This is quite bad
The Revenue for ALQGC have been decreasing by -79.70% on average. This is quite bad
EPS 1Y (TTM)87.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%92.58%
Revenue 1Y (TTM)-98.34%
Revenue growth 3Y-79.7%
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y6121.43%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1744.53%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALQGC.PA Yearly Revenue VS EstimatesALQGC.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ALQGC.PA Yearly EPS VS EstimatesALQGC.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1 2 3 4

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALQGC. In the last year negative earnings were reported.
ALQGC is valuated cheaply with a Price/Forward Earnings ratio of 0.02.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALQGC indicates a rather cheap valuation: ALQGC is cheaper than 100.00% of the companies listed in the same industry.
ALQGC's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.86.
Industry RankSector Rank
PE N/A
Fwd PE 0.02
ALQGC.PA Price Earnings VS Forward Price EarningsALQGC.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALQGC.PA Per share dataALQGC.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ALQGC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

QUANTUM GENOMICS SAS-REGR

EPA:ALQGC (10/24/2024, 7:00:00 PM)

0.0721

0 (-1.77%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)10-22 2024-10-22
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap5.00M
Analysts34.29
Price Target10.2 (14047.02%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 0.02
P/S 496.96
P/FCF N/A
P/OCF N/A
P/B 11.45
P/tB 11.45
EV/EBITDA N/A
EPS(TTM)-0.09
EYN/A
EPS(NY)4.34
Fwd EY6021.43%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS0.01
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -84.63%
ROE -726.18%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-87.78%
ROA(5y)-71.29%
ROE(3y)-517.57%
ROE(5y)-335.54%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 4.49
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.73
Quick Ratio 2.73
Altman-Z -11.61
F-ScoreN/A
WACC7.48%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)87.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%92.58%
EPS Next Y6121.43%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-98.34%
Revenue growth 3Y-79.7%
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year1744.53%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y89.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year3919.47%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A